Qiagen (NYSE:QGEN - Get Free Report) issued an update on its third quarter 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.580- for the period. The company issued revenue guidance of $522.1 million-. Qiagen also updated its FY 2025 guidance to 2.350-2.350 EPS.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the stock. Barclays assumed coverage on shares of Qiagen in a research report on Tuesday, June 24th. They set an "overweight" rating and a $55.00 price objective for the company. Wall Street Zen raised shares of Qiagen from a "buy" rating to a "strong-buy" rating in a report on Sunday. Robert W. Baird boosted their target price on shares of Qiagen from $42.00 to $43.00 and gave the stock a "neutral" rating in a report on Monday, April 21st. Finally, Bank of America boosted their target price on shares of Qiagen from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Thursday, June 26th. Seven research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Qiagen has an average rating of "Hold" and a consensus price target of $49.40.
Get Our Latest Report on Qiagen
Qiagen Stock Down 0.7%
NYSE QGEN traded down $0.34 on Tuesday, hitting $49.91. 2,073,954 shares of the company were exchanged, compared to its average volume of 1,377,790. The company has a market cap of $11.09 billion, a PE ratio of 125.14, a PEG ratio of 2.54 and a beta of 0.64. Qiagen has a 12 month low of $37.63 and a 12 month high of $51.88. The stock has a fifty day moving average of $47.71 and a 200-day moving average of $43.46. The company has a current ratio of 3.37, a quick ratio of 2.83 and a debt-to-equity ratio of 0.40.
Qiagen (NYSE:QGEN - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.60 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.60. Qiagen had a net margin of 4.68% and a return on equity of 14.61%. As a group, analysts forecast that Qiagen will post 2.26 earnings per share for the current year.
Qiagen Dividend Announcement
The firm also recently disclosed a dividend, which was paid on Thursday, July 10th. Shareholders of record on Thursday, July 3rd were issued a dividend of $0.25 per share. The ex-dividend date was Wednesday, July 2nd. This represents a yield of 52.0%. Qiagen's dividend payout ratio is presently 62.50%.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Qiagen stock. United Services Automobile Association bought a new position in shares of Qiagen N.V. (NYSE:QGEN - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 5,946 shares of the company's stock, valued at approximately $239,000. Institutional investors and hedge funds own 70.00% of the company's stock.
Qiagen Company Profile
(
Get Free Report)
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Qiagen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Qiagen wasn't on the list.
While Qiagen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.